Toxicity profile and clinical outcomes in locally advanced head and neck cancer patients treated with induction chemotherapy prior to concurrent chemoradiation

Author： Ko Eric C.   Genden Eric M.   Misiukiewicz Krzysztof   Som Peter M.   Kostakoglu Lale   Chen Chien-Ting   Packer Stuart   Kao Johnny  

Publisher： Spandidos Publications

ISSN： 1021-335X

Source： Oncology Reports, Vol.27, Iss.2, 2012-02, pp. : 467-474

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Phase I Trial of Docetaxel Based Induction and Concomitant Chemotherapy in Patients with Locally Advanced Head and Neck Cancer

By Seiwert Tanguy   Cohen Ezra   Haraf Daniel   Stenson Kerstin   Blair Elizabeth   Mauer Ann   Dekker Allison   Vokes Everett  

Cancer Investigation, Vol. 25, Iss. 6, 2007-09 ,pp. : 435-444

Informa Healthcare

Access to resources Recommend Favorite

Equivalent outcome of patients with clinical Stage IIIA non-small-cell lung cancer treated with concurrent chemoradiation compared with induction chemotherapy followed by surgical resection

By Taylor N.A.   Liao Z.X.   Cox J.D.   Stevens C.   Roth J.   Walsh G.   Chang J.Y.   Guerrero T.   Jeter M.   Putnam J.   Fossella F.V.   Allen P.   Komaki R.  

International Journal of Radiation Oncology*Biology*Physics, Vol. 58, Iss. 1, 2004-01 ,pp. : 204-212

Elsevier

Access to resources Recommend Favorite

Competing causes of death in patients with locoregionally advanced head and neck cancer treated with concomitant boost radiation plus concurrent weekly cisplatin

By Gómez-Millán Jaime  

Clinical and Translational Oncology, Vol. 15, Iss. 4, 2013-04 ,pp. : 321-326

Springer Publishing Company

Access to resources Recommend Favorite

Comparison of hyperfractionation and conventional fractionation radiotherapy with concurrent docetaxel, cisplatin and 5-fluorouracil (TPF) chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN)

By Katori Hideaki   Tsukuda Mamoru   Watai Kiichi  

Cancer Chemotherapy and Pharmacology, Vol. 60, Iss. 3, 2007-08 ,pp. : 399-406

Springer Publishing Company

Access to resources Recommend Favorite

Induction chemotherapy with cetuximab, carboplatin and paclitaxel for the treatment of locally advanced squamous cell carcinoma of the head and neck

By                

Experimental and Therapeutic Medicine, Vol. 5, Iss. 4, 2013-01 ,pp. : 1247-1253

Spandidos Publications

Access to resources Recommend Favorite